Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Apyx Medical (APYX) over the last 13 years, with Q3 2025 value amounting to $34.6 million.

  • Apyx Medical's Non-Current Debt rose 222.73% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.6 million, marking a year-over-year increase of 222.73%. This contributed to the annual value of $33.9 million for FY2024, which is 213.35% up from last year.
  • Apyx Medical's Non-Current Debt amounted to $34.6 million in Q3 2025, which was up 222.73% from $34.4 million recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Non-Current Debt registered a high of $34.6 million during Q3 2025, and its lowest value of $9.0 million during Q3 2023.
  • Moreover, its 3-year median value for Non-Current Debt was $33.9 million (2024), whereas its average is $31.1 million.
  • Examining YoY changes over the last 5 years, Apyx Medical's Non-Current Debt showed a top increase of 27576.87% in 2024 and a maximum decrease of 213.35% in 2024.
  • Quarter analysis of 3 years shows Apyx Medical's Non-Current Debt stood at $33.2 million in 2023, then increased by 2.13% to $33.9 million in 2024, then grew by 2.11% to $34.6 million in 2025.
  • Its Non-Current Debt was $34.6 million in Q3 2025, compared to $34.4 million in Q2 2025 and $34.1 million in Q1 2025.